<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1476</article-id><article-id pub-id-type="doi">10.32687/1561-5936-2022-26-4-341-346</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Features of the incidence of the working-age population of the city of Moscow by the of diseases of the circulatory system during the COVID-19 pandemic</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kuraeva</surname><given-names>V. M.</given-names></name><bio></bio><email>kuraevavm@zdrav.mos.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Podchernina</surname><given-names>A. M.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department</aff><pub-date date-type="epub" iso-8601-date="2022-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2022</year></pub-date><volume>26</volume><issue>4</issue><fpage>341</fpage><lpage>346</lpage><history><pub-date date-type="received" iso-8601-date="2022-12-06"><day>06</day><month>12</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2022,</copyright-statement><copyright-year>2022</copyright-year></permissions><abstract>Introduction. The incidence of diseases of the circulatory system among the working-age population continues to be a nationwide problem that has worsened during the COVID-19 pandemic. In Moscow, the restrictions imposed during the COVID-19 pandemic, both for the population and for medical organizations of the Moscow Healthcare Department, have become one of the reasons for the deterioration of health and an increase in the incidence of the working-age population.Aim. Analysis of the dynamics of indicators of general and primary morbidity by diseases of the circulatory system and individual nosologies of working-age population of the city of Moscow for the period 2014-2021.Materials and methods. As materials, we used Moscow Healthcare Department data (morbidity according to the data of negotiability, reporting form of the Federal Tax Service N 12) for 2014-2021, analytical and statistical methods of research, indicators of time series were used.Results. In Moscow in 2014-2021 general and primary morbidity of the working-age population in the diseases of the circulatory system decreased by 3,6% and 23,8%, diseases characterized by high blood pressure by 5.7% and 3,4%, cardiac ischemia by 13,9% and 33,4%, cerebrovascular diseases by 4,9% and 19,5%. In 2020-2021 the increase in the level of general morbidity in the class was 10,6%, diseases characterized by high blood pressure - 9,2%, cardiac ischemia - 8.1%, cerebrovascular diseases - 22%, against the background of a decrease in primary morbidity in the class by 9,3%, diseases characterized by high blood pressure by 6,3%, cardiac ischemia by 22,1%, cerebrovascular diseases by 10,2%. The number of people of working age under dispensary observation by class increased by 24,6%, diseases characterized by high blood pressure by 12,9%, cardiac ischemia by 24,6%, cerebrovascular diseases by 2 times.Conclusion. The current trends in the incidence of diseases of the circulatory system in the working-age population reflect the effectiveness of the implemented state programs and preventive measures in the metropolis, including in the context of the COVID-19 pandemic, the state of public health and adherence to prevention and treatment.</abstract><kwd-group xml:lang="en"><kwd>incidence</kwd><kwd>working-age population</kwd><kwd>diseases of the circulatory system</kwd><kwd>diseases characterized by high blood pressure</kwd><kwd>cardiac ischemia</kwd><kwd>cerebrovascular diseases</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>заболеваемость</kwd><kwd>трудоспособное население</kwd><kwd>болезни системы кровообращения</kwd><kwd>артериальная гипертензия</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>цереброваскулярные болезни</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Roth G. A., Mensah G. A., Johnson C. O. et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study //j. Am. Coll. Cardiol. 2020. Vol. 76, N 25. P. 2982-3021. DОI: 10.1016/j.jacc.2020.11.010</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Gheorghe A., Griffiths U., Murphy A. et al. The economic burden of cardiovascular disease and hypertension in low-and middle-income countries: a systematic review // BMC Public Health. 2018. Vol. 18, N 1. P. 1-11. DOI: 10.1186/s12889-01 8-5806-x</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Mendis S., Puska P., Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva; 2011.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Драпкина О. М., Дроздова Л. Ю., Авдеев С. Н. и др. Оказание амбулаторно-поликлинической медицинской помощи пациентам с хроническими заболеваниями, подлежащим диспансерному наблюдению, в условиях пандемии COVID-19. Временные методические рекомендации. Версия 2 // Кардиоваскулярная терапия и профилактика. 2021. Т. 20, № 8. Р. 3172.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Диспансерное наблюдение больных хроническими неинфекционными заболеваниями и пациентов с высоким риском их развития. Методические рекомендации / под ред. С. А. Бойцова, А. Г. Чучалина. М.; 2014. 112 с.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Калинина А. М., Кушунина Д. В., Горный Б. Э. и др. Потенциал профилактики сердечно-сосудистых заболеваний по результатам диспансеризации взрослого населения // Кардиоваскулярная терапия и профилактика. 2019. Т. 18, № 4. С. 69-76. DOI: 10115829/1728-8800-2019-4-69-76</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Конради А. О., Виллевальде С. В., Дупляков Д. В. и др. Открытое наблюдательное многоцентровое исследование (регистр) больных, перенесших новую коронавирусную инфекцию (COVID-19) с поражением сердечно-сосудистой системы или на фоне тяжелой патологии сердечно-сосудистой системы: обоснование, дизайн, значение для клинической практики // Российский кардиологический журнал. 2021. Т. 26, № 1. С. 99-104.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Железняк Н. Л., Боюшенко Е. Н., Панов А. В., Танова А. А. Медико-статистический анализ показателей реализации регионального проекта «Борьба с сердечно-сосудистыми заболеваниями» // Главврач Юга России. 2020. № 4. С. 9-12.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Михайловская Т. В., Яковлева Н. Д., Сафронов М. А., Харламова Я. И. Потенциальное влияние COVID-19 на сердечно-сосудистую систему // Физическая и реабилитационная медицина, медицинская реабилитация. 2020. Т. 2, № 2. С. 133-139. DOI: https://doi.org/10.36425/rehab34080</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Барбараш О. Л., Каретникова В. Н., Кашталап В. В. и др. Новая коронавирусная болезнь (COVID-19) и сердечно-сосудистые заболевания // Комплексные проблемы сердечно-сосудистых заболеваний. 2020. Т. 9, № 2. С. 17-28. DOI: 10.17802/2306-1278-2020-9-2-17-28</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Yusuf S., Joseph P., Rangarajan S. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study // Lancet. 2020. Vol. 395, N 10226. P. 795-808. DOI: 10.1016/S0140-6736(19)32008-2</mixed-citation></ref></ref-list></back></article>
